| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/1994 | CA1325976C Azelastine-containing medicaments with controlled release of the active substance |
| 01/11/1994 | CA1325975C Controlled release of antibiotic salts from an implant |
| 01/09/1994 | CA2100045A1 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic .beta. - cyclodextrin derivatives, a proce ss for the preparation thereof and the use thereof |
| 01/09/1994 | CA2100007A1 Preparation of new amido-alcohol derivatives and their therapeutical applications |
| 01/09/1994 | CA2097248A1 Substituted phenylimidazolidines, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 01/09/1994 | CA2097247A1 Phenylimidazolidines, substituted or not, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 01/09/1994 | CA2073479A1 Synergistic compositions |
| 01/08/1994 | CA2099789A1 Treatment of inflammatory bowel disease |
| 01/06/1994 | WO1994000758A1 A novel in vitro method of screening potential anticancer drugs using a cell differentiation assay |
| 01/06/1994 | WO1994000596A1 Acceptor for fucosyltransferase |
| 01/06/1994 | WO1994000573A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | WO1994000558A1 DIABETOGENE rad: A TYPE II DIABETES SPECIFIC GENE |
| 01/06/1994 | WO1994000531A1 Luminescent article with high pigment to binder ratio and manufacture thereof |
| 01/06/1994 | WO1994000530A1 Luminescent article with high phosphor to binder ratio and manufacture thereof |
| 01/06/1994 | WO1994000480A1 Steroidal glycosides for treating hypercholesterolemia |
| 01/06/1994 | WO1994000477A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 01/06/1994 | WO1994000476A1 Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract |
| 01/06/1994 | WO1994000467A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | WO1994000465A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 01/06/1994 | WO1994000462A1 Novel crystal of monohydrate of heterocyclic bis(phosphonic acid) derivative |
| 01/06/1994 | WO1994000458A1 N-substituted 3-azabicyclo[3.2.0]heptane derivates useful as neuroleptic agents, etc. |
| 01/06/1994 | WO1994000457A1 Alphalosporins and 1-carba-1-dethia cephalosporins |
| 01/06/1994 | WO1994000453A1 Purinone antianginal agents |
| 01/06/1994 | WO1994000451A1 9-AMINOPYRIDAZINO[4',5' : 3,4]pyrrolo[2,1-a]ISOQUINOLINES AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS |
| 01/06/1994 | WO1994000448A1 Azacyclic and azabicyclic hydroxylamines as muscarinic receptor agonists |
| 01/06/1994 | WO1994000447A1 Novel cyclic lipid derivatives as potent paf antagonists |
| 01/06/1994 | WO1994000444A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 01/06/1994 | WO1994000443A1 Fungicidally active compounds |
| 01/06/1994 | WO1994000442A1 1-aryl(4-o-alkoxyphenyl 1-piperazinyl)-2, -3 or -4 alkanols, process for their preparation and use thereof in the preparation of drugs |
| 01/06/1994 | WO1994000441A1 N(hetero)-aryl-n(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 01/06/1994 | WO1994000440A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/06/1994 | WO1994000437A1 Pharmaceutical pyridine compounds |
| 01/06/1994 | WO1994000435A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | WO1994000434A1 Novel nicotinic acid esters |
| 01/06/1994 | WO1994000433A1 Process for making phenylthiomethylpyridinylalkenoates |
| 01/06/1994 | WO1994000432A1 Anorectic epinephrine derivatives |
| 01/06/1994 | WO1994000431A1 N-substitued 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents etc. |
| 01/06/1994 | WO1994000429A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 01/06/1994 | WO1994000428A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
| 01/06/1994 | WO1994000419A1 Inhibitors of farnesyl protein transferase |
| 01/06/1994 | WO1994000417A1 Zinc tranexamate compound |
| 01/06/1994 | WO1994000180A1 Methods and devices for relaxing smooth muscle contractions |
| 01/06/1994 | WO1994000164A1 Sustained release alginate fibre and process for the preparation thereof |
| 01/06/1994 | WO1994000161A1 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids |
| 01/06/1994 | WO1994000141A1 Glutathione as chemoprotective agent |
| 01/06/1994 | WO1994000138A1 Airborne protectants against oxidative tissue damage |
| 01/06/1994 | WO1994000135A1 Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases |
| 01/06/1994 | WO1994000134A1 Preventing tissue adhesion using in situ modification of alginate |
| 01/06/1994 | WO1994000132A1 Use of guanosine and its precursors and derivatives in the manufacture of drugs for the treatment of brain dysfunction |
| 01/06/1994 | WO1994000131A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | WO1994000130A1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
| 01/06/1994 | WO1994000129A1 Use of phosphonates for the treatment of osteoporosis |
| 01/06/1994 | WO1994000128A1 ORAL 1α-HYDROXYPREVITAMIN D |
| 01/06/1994 | WO1994000127A1 Lipids for epidermal moisturization and repair of barrier function |
| 01/06/1994 | WO1994000126A1 The use of bile acids as antiviral agents |
| 01/06/1994 | WO1994000125A1 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS |
| 01/06/1994 | WO1994000124A1 Glycine receptor antagonists and the use thereof |
| 01/06/1994 | WO1994000123A1 Micro-emulsion of dexniguldipin |
| 01/06/1994 | WO1994000122A1 Use of condensed bis-(3,4-dihydro-pyridinyl)methane for treating crohn's disease, colitis ulcerosa, chronic inflamatory processes and as an antiproliferative |
| 01/06/1994 | WO1994000121A1 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors |
| 01/06/1994 | WO1994000120A1 Chemical compounds |
| 01/06/1994 | WO1994000118A1 Production and use of imines of porphyrins |
| 01/06/1994 | WO1994000117A1 Pharmaceutical agent with antitumoral activity |
| 01/06/1994 | WO1994000116A1 Agent with adaptogenic activity |
| 01/06/1994 | WO1994000114A1 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
| 01/06/1994 | WO1994000113A2 Medicaments containing 5-ht4 receptor antagonists |
| 01/06/1994 | WO1994000112A1 An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
| 01/06/1994 | WO1994000109A1 Dermatological agent for aiding oxygen transport in the skin |
| 01/06/1994 | WO1994000101A1 Prophylactic and therapeutical preparation against caries |
| 01/06/1994 | WO1994000098A1 Cosmetic containing phospholipids and fluorocarbon compounds |
| 01/06/1994 | WO1994000095A2 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | WO1994000047A1 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine |
| 01/06/1994 | WO1993016701A3 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | WO1993014743A3 Polar c-1 esters of prostaglandins |
| 01/06/1994 | WO1992009573A3 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/06/1994 | EP0583359A4 Method for treating hypothermia. |
| 01/06/1994 | CA2147348A1 Airborne protectants against oxidative tissue damage |
| 01/06/1994 | CA2139414A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 01/06/1994 | CA2139311A1 In situ modification of alginate |
| 01/06/1994 | CA2139116A1 1-aryl (o-alcoxyphenyl-4 piperazinyl-1)-2, -3 or -4 alcanols, their preparation and their use for the preparation of medications |
| 01/06/1994 | CA2139104A1 Steroidal glycosides for treating hypercholesterolemia |
| 01/06/1994 | CA2139000A1 Methods and compositions for treating depression and other disorders using optically pure(+) sibutramine |
| 01/06/1994 | CA2138998A1 Methods and compositions for treating depression and other disorders using optically pure(-) sibutramine |
| 01/06/1994 | CA2138992A1 Glutathione as chemoprotective agent |
| 01/06/1994 | CA2138989A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
| 01/06/1994 | CA2138956A1 17-alkylketone steroids useful as 5-.alpha.-reductase inhibitors |
| 01/06/1994 | CA2138955A1 Process for making phenylthiomethylpyridinylalkenoates |
| 01/06/1994 | CA2138954A1 Pharmaceutical pyridine compounds |
| 01/06/1994 | CA2138807A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | CA2138791A1 9-aminopyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | CA2138788A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | CA2138780A1 Prophylactic and therapeutical preparation against caries |
| 01/06/1994 | CA2138770A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | CA2138645A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 01/06/1994 | CA2138538A1 Production and use of imines of porphyrins |
| 01/06/1994 | CA2138389A1 Bis-(substituted-phenyl) derivatives with cytotoxic and anticancer activity |
| 01/06/1994 | CA2138281A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | CA2138167A1 Use of condensed bis-(3,4-dihydro-1-pyridinyl)methanes for treating crohn's disease, ulcerative colitis, chronic inflammatory processes and as antiproliferative agents |
| 01/06/1994 | CA2138124A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |